U.S. Pharma Stock News

Apogee Therapeutics reported a full-year net loss of US$255.84 million for 2025, with basic and diluted loss per share of US$4.22 as it continued to report no product revenue while investing heavily in its antibody pipeline. Alongside deeper losses, the company underscored upcoming clinical milestones for zumilokibart and other programs and filed a US$287.29 million shelf registration tied to an employee stock ownership plan, highlighting both capital needs and efforts to align employee...

Astera Labs has recently deepened its AI data center role by acquiring aiXscale Photonics, expanding with an Israel Design Center, and advancing its vendor‑neutral connectivity solutions through UALink participation and hyperscaler partnerships. This expansion into optical interconnects and closer collaboration with major cloud providers could reinforce Astera Labs’ position as a key infrastructure enabler in next‑generation AI data centers. We’ll now examine how the aiXscale Photonics...

ImmunityBio (IBRX) is back in focus after completing enrollment ahead of schedule in its Phase 2 ANKTIVA bladder cancer trial. Interim data show statistically significant response durability compared with BCG alone and no significant safety concerns. See our latest analysis for ImmunityBio. The latest ANKTIVA trial update arrives after a significant 3-month share price return of about 3.7x and a 416.83% year-to-date share price return, alongside a 245.70% 1-year total shareholder return. This...

HCA Healthcare director Robert J. Dennis plans to retire from the board at the upcoming annual meeting. He will not stand for re election, which will reduce the current slate of directors following the meeting. The transition focuses attention on HCA Healthcare’s board composition and future oversight of the business. For investors watching NYSE:HCA, this board change comes at a time when the company’s shares are trading around $532.92. The stock has seen a 13.3% return year to date and a...

Clover Health Investments (NasdaqGS:CLOV) reports very large year over year growth in third party clinician adoption of its Counterpart Health platform. The technology is now used widely outside the company’s own plans, with third party adoption described as more than 4.5x higher year over year. Counterpart Health has achieved a top HEDIS score nationally for a PPO Medicare Advantage plan with a non employed physician network. Clover Health Investments, listed on NasdaqGS:CLOV, runs...

Why Axon’s latest results caught investor attention Axon Enterprise (AXON) drew fresh interest after releasing fourth quarter and full year 2025 results, showing higher revenue alongside much lower net income, and pairing that with new 2026 guidance that calls for 27% to 30% revenue growth. See our latest analysis for Axon Enterprise. The earnings release and 2026 guidance arrived alongside a sharp short term move, with a 35.1% 7 day share price return and a 5.5% 1 day gain. The 3 year total...

Moody’s Corporation recently reported higher fourth-quarter and full-year 2025 results, continued its share repurchase program, filed a shelf registration for new debt securities, and earlier in February opened a new regional headquarters in Riyadh to deepen its presence in Saudi Arabia and the wider Middle East. Together, stronger earnings and the Riyadh regional hub highlight how Moody’s is pairing profit growth with a broader international footprint in a key capital‑markets region. We’ll...

NVR recently reported its fourth-quarter 2025 results, with earnings and Homebuilding revenue coming in ahead of consensus estimates despite weaker housing demand and affordability pressures. An interesting wrinkle is that, even with this earnings beat, analyst estimates for NVR have generally moved lower, pointing to a more cautious outlook on future performance. Next, we will examine how beating expectations amid softer housing demand shapes NVR's investment narrative for investors...

Setting the scene: Berkshire Hathaway’s recent performance snapshot Berkshire Hathaway (BRK.B) has seen its share price roughly flat over the past month, with a small 1 day decline and modest pullback over the past 3 months and year to date. See our latest analysis for Berkshire Hathaway. The recent 1 day share price return of a 4.91% decline at Berkshire Hathaway fits into a softer trend, with the 90 day share price return of a 5.23% decline contrasting with a 51.49% three year total...

Synopsys (NasdaqGS:SNPS) has appointed former Deloitte executive Peter A. Shimer to its board of directors and Audit Committee. Shimer brings long-tenured leadership experience and involvement in AI-driven cancer research to Synopsys' governance bench. Separately, Innatera has selected Synopsys tools for design validation of neuromorphic edge AI microcontrollers used at the sensor level. Synopsys, trading at $424.66, sits at the intersection of chip design tools and AI-centric computing,...

Taiwan Semiconductor Manufacturing (TSM) is back in focus after recent share price swings, with the stock showing a 1.5% decline on the day but a positive pattern over longer periods. See our latest analysis for Taiwan Semiconductor Manufacturing. Those short term share price moves sit within a stronger trend, with a 30 day share price return of 11.66% and a 90 day share price return of 26.37%. Meanwhile, the 1 year total shareholder return of 115.64% and very large 3 year total shareholder...

If you are wondering whether Pool at around US$222 still lines up with what it might be worth, you are not alone and this article is set up to help you frame that question clearly. The share price has moved 1.6% over the last 7 days, while returns sit at a 12.6% decline over 30 days, a 3.4% decline year to date, and declines of 34.4% over 1 year, 35.2% over 3 years and 28.3% over 5 years, which will affect how many investors view its growth potential and risk. Recent coverage around Pool has...

Union Pacific (NYSE:UNP) and Norfolk Southern have announced a proposed merger to create what would be the first fully transcontinental freight railroad in the U.S. The combined network would link Atlantic and Pacific gateways and is intended to streamline coast to coast freight movements. The deal is subject to regulatory review and approval before any integration of operations can occur. For investors tracking Union Pacific, the news coincides with the stock at $266.97 and multi year...

uniQure (QURE) has just wrapped up FY 2025 with fourth quarter revenue of US$5.6 million and a basic EPS loss of US$0.59, as net income excluding extra items came in at a loss of US$37.1 million. Over recent quarters, the company has seen revenue move between US$1.6 million and US$5.6 million while basic EPS ranged from a loss of US$0.59 to a loss of US$1.38. This gives investors a clear picture of a business that is still in heavy investment mode rather than focused on near term...

If you are wondering whether NBT Bancorp is reasonably priced or offering a margin of safety at its current US$42.78 share price, you are in the right place to get a clear, valuation focused view. The stock has slipped 2.0% over the last week and 3.7% over the last month, while still showing a 2.9% return year to date and longer term returns of 21.9% over 3 years and 22.7% over 5 years. These movements may signal shifting views on both its potential and its risks. Recent coverage of regional...

United States Antimony (UAMY) has stepped into the spotlight after back to back appearances at the BMO Global Metals, Mining & Critical Minerals Conference and PDAC 2026, supported by fresh investor materials on its integrated North American platform. See our latest analysis for United States Antimony. The recent conference appearances and supply chain updates come against a backdrop of strong momentum, with a 90 day share price return close to 99% and a very large 1 year total shareholder...

LXP Industrial Trust (LXP) has put fresh numbers in front of investors with its Q4 2025 investor presentation, spotlighting 97.1% portfolio occupancy and a new approximately 1 million square foot Phoenix development tied to strong industrial demand. See our latest analysis for LXP Industrial Trust. At a share price of $49.09, LXP Industrial Trust has seen a 15.53% 1 year total shareholder return, even though its year to date share price return is slightly negative and short term moves remain...

Sea Limited recently confirmed it would release its fourth quarter 2025 results and host its earnings call on March 3, 2026, at 9:30 a.m. US Eastern Standard Time. This upcoming update follows a period where investors have become more focused on a projected slowdown in Sea’s revenue growth momentum. We’ll now examine how expectations for slower year-on-year revenue growth heading into this earnings release may influence Sea’s investment narrative. Uncover the next big thing with 30 elite...

BigBear.ai Holdings (BBAI) has caught investor attention after recent trading, with the share price closing at US$4.10 and short term returns showing sharp moves over the past month and over the past 3 months. See our latest analysis for BigBear.ai Holdings. Those recent sharp short term share price moves sit against a tougher backdrop, with a 30 day share price return of 18.65% and a 90 day return of 29.19%, while the 1 year total shareholder return of 13.87% contrasts with a 3 year total...

If you are wondering whether Alignment Healthcare is attractively priced at its current level, this article will walk through how the market might be valuing the stock today and what that could mean for you. The share price closed at US$19.65 recently, with returns of a 1.3% decline over the last week, a 12.8% decline over the last month, a 2.8% decline year to date, and a 26.6% gain over the past year, as well as a very large gain over three years. These moves have come alongside ongoing...

Why Schneider National Stock Is Getting Attention Now With no single headline event setting the tone, Schneider National (SNDR) is drawing interest as investors weigh its recent share performance, profitability metrics, and scale across truckload, intermodal, and logistics operations. See our latest analysis for Schneider National. Schneider National’s recent share price has been relatively firm at US$28.16, with a 20.14% 90 day share price return and a 9.73% 1 year total shareholder return...

Datadog (NasdaqGS:DDOG) has entered a new partnership with Sakana AI focused on enterprise AI adoption and joint research. The collaboration targets large enterprises in Japan first, with an intention to extend offerings to global customers over time. Both companies plan to combine Datadog's cloud and monitoring capabilities with Sakana AI's scalable models for real world deployments. Datadog, trading at around $111.11, sits in an interesting spot for investors reviewing its recent...

Boeing (NYSE:BA) has secured major jet deals with Vietnamese airlines, including what has been described as the largest-ever wide-body order by a Vietnamese carrier. The company has also signed a significant single aisle aircraft agreement with Vietnam’s national airline. In 2025, Boeing reported more plane orders than Airbus for the first time in seven years. These developments follow efforts to address production issues and strengthen quality controls. Boeing is a global aerospace...

Nexa Resources S.A. reported a turnaround in its 2025 results, with sales of US$3,002.06 million, net income of US$132.63 million, a US$12.5 million impairment on long-lived assets, and a proposed dividend of about US$17.5 million (US$0.132136 per share) for payment in August 2026, subject to AGM approval. The company’s return to profitability alongside a proposed cash dividend, while reaffirming 2026 production guidance after only minimal disruption at the Atacocha mine, highlights...